ArticleClinical pharmacology in drug development2022

Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase Inhibitor.

Xiaoyan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.